These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1650931)

  • 21. Metabolic changes in normal-appearing white matter in patients with neuromyelitis optica and multiple sclerosis: a comparative magnetic resonance spectroscopy study.
    Duan Y; Liu Z; Liu Y; Huang J; Ren Z; Sun Z; Chen H; Dong H; Ye J; Li K
    Acta Radiol; 2017 Sep; 58(9):1132-1137. PubMed ID: 28173728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proton MRS of gadolinium-enhancing MS plaques and metabolic changes in normal-appearing white matter.
    Roser W; Hagberg G; Mader I; Brunnschweiler H; Radue EW; Seelig J; Kappos L
    Magn Reson Med; 1995 Jun; 33(6):811-7. PubMed ID: 7651118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Corpus callosum axonal injury in multiple sclerosis measured by proton magnetic resonance spectroscopic imaging.
    Oh J; Pelletier D; Nelson SJ
    Arch Neurol; 2004 Jul; 61(7):1081-6. PubMed ID: 15262739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proton magnetic resonance spectroscopy in multiple sclerosis.
    Wolinsky JS; Narayana PA; Fenstermacher MJ
    Neurology; 1990 Nov; 40(11):1764-9. PubMed ID: 2172865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proton magnetic resonance spectroscopy of normal appearing white matter in familial and sporadic multiple sclerosis.
    Siger-Zajdel M; Selmaj KW
    J Neurol; 2005 Jul; 252(7):830-2. PubMed ID: 15772740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discrimination of white matter lesions and multiple sclerosis plaques by short echo quantitative 1H-magnetic resonance spectroscopy.
    Kapeller P; Ropele S; Enzinger C; Lahousen T; Strasser-Fuchs S; Schmidt R; Fazekas F
    J Neurol; 2005 Oct; 252(10):1229-34. PubMed ID: 15895306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions.
    Davie CA; Hawkins CP; Barker GJ; Brennan A; Tofts PS; Miller DH; McDonald WI
    Brain; 1994 Feb; 117 ( Pt 1)():49-58. PubMed ID: 8149214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is magnetic resonance spectroscopy capable of detecting metabolic abnormalities in neurofibromatosis type 1 that are not revealed in brain parenchyma of normal appearance?
    Rodrigues AC; Ferraz-Filho JR; Torres US; da Rocha AJ; Muniz MP; Souza AS; Goloni-Bertollo EM; Pavarino ÉC
    Pediatr Neurol; 2015 Mar; 52(3):314-9. PubMed ID: 25585912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regression analysis of metabolite concentrations estimated from localized proton MR spectra of active and chronic multiple sclerosis lesions.
    Helms G; Stawiarz L; Kivisäkk P; Link H
    Magn Reson Med; 2000 Jan; 43(1):102-10. PubMed ID: 10642736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T.
    Srinivasan R; Sailasuta N; Hurd R; Nelson S; Pelletier D
    Brain; 2005 May; 128(Pt 5):1016-25. PubMed ID: 15758036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic profiles by 1H-magnetic resonance spectroscopy in natalizumab-associated post-PML lesions of multiple sclerosis patients who survived progressive multifocal leukoencephalopathy (PML).
    Schneider R; Bellenberg B; Hoepner R; Kolb EM; Ellrichmann G; Haghikia A; Gold R; Lukas C
    PLoS One; 2017; 12(4):e0176415. PubMed ID: 28445498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques.
    Arnold DL; Matthews PM; Francis GS; O'Connor J; Antel JP
    Ann Neurol; 1992 Mar; 31(3):235-41. PubMed ID: 1637131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diffusely elevated cerebral choline and creatine in relapsing-remitting multiple sclerosis.
    Inglese M; Li BS; Rusinek H; Babb JS; Grossman RI; Gonen O
    Magn Reson Med; 2003 Jul; 50(1):190-5. PubMed ID: 12815694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proton MR spectroscopy of lesion evolution in multiple sclerosis: Steady-state metabolism and its relationship to conventional imaging.
    Kirov II; Liu S; Tal A; Wu WE; Davitz MS; Babb JS; Rusinek H; Herbert J; Gonen O
    Hum Brain Mapp; 2017 Aug; 38(8):4047-4063. PubMed ID: 28523763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proton MR spectroscopic characterization of differences in regional brain metabolic abnormalities in mitochondrial encephalomyopathies.
    Mathews PM; Andermann F; Silver K; Karpati G; Arnold DL
    Neurology; 1993 Dec; 43(12):2484-90. PubMed ID: 8255444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relative metabolite concentrations and ratios determined by use of 3-T region-specific proton magnetic resonance spectroscopy of the brain of healthy Beagles.
    Warrington CD; Feeney DA; Ober CP; Jessen CR; Steward SM; Armién AG; Fletcher TF
    Am J Vet Res; 2013 Oct; 74(10):1291-303. PubMed ID: 24066913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hydrogen proton magnetic resonance spectroscopy in autism: preliminary evidence of elevated choline/creatine ratio.
    Sokol DK; Dunn DW; Edwards-Brown M; Feinberg J
    J Child Neurol; 2002 Apr; 17(4):245-9. PubMed ID: 12088077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proton MR spectroscopy with metabolite-nulling reveals elevated macromolecules in acute multiple sclerosis.
    Mader I; Seeger U; Weissert R; Klose U; Naegele T; Melms A; Grodd W
    Brain; 2001 May; 124(Pt 5):953-61. PubMed ID: 11335697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebral metabolism in experimental hydrocephalus: an in vivo 1H and 31P magnetic resonance spectroscopy study.
    Braun KP; van Eijsden P; Vandertop WP; de Graaf RA; Gooskens RH; Tulleken KA; Nicolay K
    J Neurosurg; 1999 Oct; 91(4):660-8. PubMed ID: 10507389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The association between retinal nerve fibre layer thickness and N-acetyl aspartate levels in multiple sclerosis brain normal-appearing white matter: a longitudinal study using magnetic resonance spectroscopy and optical coherence tomography.
    Pardini M; Botzkowski D; Müller S; Vehoff J; Kuhle J; Ruberte E; Würfel J; Gass A; Valmaggia C; Tettenborn B; Putzki N; Yaldizli Ö
    Eur J Neurol; 2016 Dec; 23(12):1769-1774. PubMed ID: 27591406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.